Clin2
NCT07774533Possibly a fitRecruiting

Imaging osteosarcoma with a new PET tracer

OsteosarcomaOsteosarcoma, Recurrent, Refractory

Part of Cancer clinical trials.

This trial tests a new PET imaging tracer that may help see osteosarcoma tumors more clearly. It is for people whose osteosarcoma has not improved or has returned after standard treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
16 people
Ages
10 years to 80 years
Study type
Interventional

Who can take part

  • You must be at least 10 years old.
  • You must have a confirmed diagnosis of osteosarcoma.
  • Your cancer must have returned or not responded to at least one or two lines of standard treatment.
  • You must be able to understand the study and give consent (or have a parent or guardian consent for you).
  • You must be able to undergo a PET/CT scan.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06778603Recruiting· Phase 1/Phase 2
Using B7-H3 imaging to guide osteosarcoma surgery

This trial tests a special dye that targets B7-H3, a protein found on osteosarcoma cells. Before your surgery, the dye is injected and helps surgeons see tumor edges more clearly, so they can remove all of the cancer while saving healthy tissue.

Beijing, Beijing Municipality
NCT06454955Recruiting· Early Phase 1
PET scan imaging study for solid tumors using a new probe

This trial tests a new imaging agent that targets a protein called B7-H3 found on many solid tumors. It uses PET/CT to help doctors see and stage tumors more clearly.

Beijing, Beijing Municipality
NCT06646952Recruiting
PET imaging of solid tumors with a CD147-targeting probe

This trial tests a special imaging agent (a nanobody probe) that targets a protein called CD147 on tumor cells. If you have a solid tumor like melanoma, liver, colorectal, pancreatic, breast, stomach, or lung cancer, the PET scan may help doctors see your cancer more clearly.

Beijing, Beijing Municipality
NCT07023640Recruiting
Imaging test for tumors using a new tracer agent

This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.

Beijing, Beijing Municipality
NCT07254104Enrolling by invitation· Early Phase 1
PET imaging for hard-to-treat pituitary tumors

This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.

Beijing
NCT07760012Recruiting
PET/CT scan for common solid tumors

This trial uses a new kind of PET/CT scan to take detailed pictures of solid tumors such as melanoma, liver, lung, breast, pancreatic, or ovarian cancer. The scan might help doctors find cancer more clearly.

Beijing, Beijing Municipality

Hear when a new Osteosarcoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.